Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button

Home > Press > Applied Nanoscience Issues Progress Report

Abstract:
Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN) today issued the following progress report:

Applied Nanoscience Issues Progress Report

CARLSBAD, CA | Posted on March 6th, 2008

Testing of filter samples incorporating the company's proprietary silver nanoparticle formulation were tested after a simulated one-year aging process and proved to be highly effective in eradicating avian influenza. An independent BSL-3 laboratory reported a 3.6 log reduction (equivalent to a 99.96% reduction) in the avian influenza simulant H9N2 when exposed to the one-year aged nanoparticle enhanced filter media.

The technology, which has been under development for the past several years, has demonstrated effectiveness against a broad range of other pathogens, such as Staphylococcus aureus, Streptococcus pneumoniae, and the drug resistant S. aureus MRSA.

"We are very encouraged at the sustained progress made with our Nanoparticle - Enhanced - Filtration - Technology platform. The continued focus of our scientific team to include recent scale-up success has put us in a position to begin targeting license partners in a number of consumer markets," said Thomas Allen, President and CEO, ANI.

On February 8, 2008 Applied Nanoscience filed a Form 10-SB under Section 12(g) of The Securities Exchange Act of 1934 to become a fully reporting company. Filing this document one of the necessary steps the company must take to advance to the OTC Bulletin Board (OTCBB). An eventual listing on the OTCBB is expected to enhance the company's profile in public equity markets and make it easier to attract financing.

####

About Applied Nanoscience Inc.
Applied Nanoscience Inc. is a marketer and developer of innovative, high-performance filtration products, systems and technologies to customers worldwide in a focused effort to provide a safer tomorrow.

For more information, please click here

Contacts:
Philippe Niemetz
PAN Consultants Ltd.
800-477-7570
or
212-344-6464

Investor Relations

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Scientists change properties of zeolites to improve hemodialysis July 29th, 2016

Novel state of matter: Observation of a quantum spin liquid July 29th, 2016

A new type of quantum bits July 29th, 2016

Lonely atoms, happily reunited July 29th, 2016

Investments/IPO's/Splits

Nanometrics Announces Upcoming Investor Events July 20th, 2016

Keystone Nano selected as a top scoring company by NCI investor review panel July 19th, 2016

Arrowhead Pharmaceuticals to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference July 6th, 2016

Nanometrics to Participate in the 8th Annual CEO Investor Summit: Investor Event Held Concurrently with SEMICON West 2016 in San Francisco June 22nd, 2016

Announcements

Scientists change properties of zeolites to improve hemodialysis July 29th, 2016

Novel state of matter: Observation of a quantum spin liquid July 29th, 2016

A new type of quantum bits July 29th, 2016

Lonely atoms, happily reunited July 29th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic